Synthesis and biological evaluation of 2',3'-didehydro-2',3'-dideoxy-9-deazaguanosine, a monophosphate prodrug and two analogues, 2',3'-dideoxy-9-deazaguanosine and 2',3'-didehydro-2',3'-dideoxy-9-deazainosine.
Abstract |
2',3'-Didehydro-2',3'-dideoxy-9-deazaguanosine (1), its monophosphate prodrug (2), and two analogues, 2',3'-dideoxy-9-deazaguanosine (3) and 2',3'-didehydro-2',3'-dideoxy-9-deazainosine (4), have been synthesized from benzoylated 9-deazaguanosine (5). Basic hydrolysis of 5, selective protection of the 2-amino and 5'-hydroxy functions with isobutyryl and silyl groups, respectively, followed by reaction with thiocarbonyldiimidazole gave the cyclic thiocarbonate, which, upon reaction with triethyl phosphite, followed by deprotection, afforded 1. Treatment of 1 with phenyl methoxyalaninylphosphochloridate and N-methylimidazole gave 2. Catalytic hydrogenation of 1 gave 3. Hydrodediazoniation of 1 with tert- butyl nitrite and tris(trimethylsilyl)silane gave 4. Compounds 1-4 were found to be inactive against the human immunodeficiency virus and exhibited minimal to no cytotoxic activity against the L1210 leukemia, CCRF-CEM lymphoblastic leukemia, and B16F10 melanoma in vitro.
|
Authors | Mao-Chin Liu, Mei-Zhen Luo, Diane E Mozdziesz, Ginger E Dutschman, Elizabeth A Gullen, Yung-Chi Cheng, Alan C Sartorelli |
Journal | Nucleosides, nucleotides & nucleic acids
(Nucleosides Nucleotides Nucleic Acids)
Vol. 24
Issue 2
Pg. 135-45
( 2005)
ISSN: 1525-7770 [Print] United States |
PMID | 15822619
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Prodrugs
- Inosine
- 9-deazainosine
- Deoxyguanosine
|
Topics |
- Cell Line, Tumor
- Deoxyguanosine
(analogs & derivatives, chemical synthesis, pharmacology)
- HIV
(drug effects)
- Hematologic Neoplasms
(drug therapy)
- Humans
- Inosine
(analogs & derivatives, chemical synthesis, pharmacology)
- Prodrugs
(chemical synthesis, pharmacology)
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|